Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GNG11 |
| Upstream (Parents) |
|---|
| (<<) ECM2 → GNG11 |
| (<<) LDB2 → GNG11 |
| (<<) GIMAP6 → GNG11 |
| (<<) MMRN2 → GNG11 |
| Downstream (Children) |
|---|
| GNG11 → CDH5 (>>) |
| GNG11 → ZNF135 (>>) |
| GNG11 → SPATA1 (>>) |
| GNG11 → MAK (>>) |
| GNG11 → GPR4 (>>) |
| GNG11 → LDB2 (>>) |
| GNG11 → OLFML1 (>>) |
| GNG11 → AXL (>>) |
| GNG11 → DHRS12 (>>) |
| GNG11 → PECAM1 (>>) |
| GNG11 → EMCN (>>) |
| GNG11 → PDE1A (>>) |
| GNG11 → GJA4 (>>) |
| GNG11 → JAM2 (>>) |
| GNG11 → SYNPO (>>) |
| GNG11 → MMRN2 (>>) |
| GNG11 → MAGEH1 (>>) |
| GNG11 → COPZ2 (>>) |
| GNG11 → PCDH17 (>>) |
